Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS)
CNY 10.84
(0.18%)
CNY 10.84
(0.18%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 679.7 Million CNY | 28.35% |
| 2022 | 529.55 Million CNY | -0.58% |
| 2021 | 532.64 Million CNY | 21.33% |
| 2020 | 439 Million CNY | 43.48% |
| 2019 | 305.97 Million CNY | 69.99% |
| 2018 | 180 Million CNY | 171.54% |
| 2017 | 66.28 Million CNY | 1.67% |
| 2016 | 65.2 Million CNY | 226.0% |
| 2015 | 20 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 771.36 Million CNY | -13.33% |
| 2024 Q2 | 759.56 Million CNY | -12.94% |
| 2024 Q1 | 872.42 Million CNY | 28.35% |
| 2023 Q3 | 696.9 Million CNY | 13.4% |
| 2023 Q4 | 679.7 Million CNY | -2.47% |
| 2023 Q1 | 483.5 Million CNY | -8.7% |
| 2023 Q2 | 614.56 Million CNY | 27.11% |
| 2023 FY | 679.7 Million CNY | 28.35% |
| 2022 Q4 | 529.55 Million CNY | 9.65% |
| 2022 Q3 | 482.95 Million CNY | -26.14% |
| 2022 Q2 | 653.89 Million CNY | 18.52% |
| 2022 Q1 | 551.71 Million CNY | 3.58% |
| 2022 FY | 529.55 Million CNY | -0.58% |
| 2021 Q4 | 532.64 Million CNY | -14.09% |
| 2021 Q2 | 556.13 Million CNY | 30.84% |
| 2021 Q3 | 619.98 Million CNY | 11.48% |
| 2021 FY | 532.64 Million CNY | 21.33% |
| 2021 Q1 | 425.04 Million CNY | -3.18% |
| 2020 Q1 | 380.78 Million CNY | 24.45% |
| 2020 Q2 | 309.86 Million CNY | -18.62% |
| 2020 Q3 | 329.86 Million CNY | 6.45% |
| 2020 Q4 | 439 Million CNY | 33.09% |
| 2020 FY | 439 Million CNY | 43.48% |
| 2019 Q3 | 305.34 Million CNY | 45.4% |
| 2019 Q2 | 210 Million CNY | 23.53% |
| 2019 Q4 | 305.97 Million CNY | 0.21% |
| 2019 FY | 305.97 Million CNY | 69.99% |
| 2019 Q1 | 170 Million CNY | -5.56% |
| 2018 Q1 | 31.48 Million CNY | -52.5% |
| 2018 FY | 180 Million CNY | 171.54% |
| 2018 Q4 | 180 Million CNY | -4.38% |
| 2018 Q3 | 188.25 Million CNY | 54.95% |
| 2018 Q2 | 121.48 Million CNY | 285.81% |
| 2017 Q4 | 66.28 Million CNY | -64.78% |
| 2017 Q1 | 70.2 Million CNY | 7.67% |
| 2017 Q3 | 188.23 Million CNY | 168.14% |
| 2017 FY | 66.28 Million CNY | 1.67% |
| 2017 Q2 | 70.2 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 65.2 Million CNY | 226.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q4 | 65.2 Million CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 FY | 20 Million CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |